Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of Croma Ophthalmic Solution Containing Sodium Cromoglycate (40 mg/ml) and Tetrahydrozoline Hydrochloride (0.5 mg/ml) in Subjects with Chronic Allergic Conjunctivitis and Hay Fever (Seasonal)	Jamjoom Pharmaceuticals	Completed	Croma	4	CROMA001	King Khalid University Hospital (Riyadh)
The Effect of Sulfad tablet on Hepatitis B & C, achieving a sustained response	Northren Area Armed Force Hospital	Completed	Sulfad	3	Protocol dated: 2011	Northren Area Armed Force Hospital
A 26-week, Randomized, Double-blinded, Placebo controlled study to explore the Effects of Probiotics on Endotoxin Levels in patients with Type 2 Diabetes Mellitus	"Prince Mutaib bin Abdullah Chair for Biomarkers Research on Osteoporosis"	Completed	Probiotics	3	STRP-10	King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Riyadh), Minstery of Health
Alleviating Post Surgical Dental Pain	Julphar	Rejected	Profinal XP 400 mg F.C Tablet	4	1/2010/PXP/JUL	N/A
"Prospective Observational Clinical Practice Study in the 1st LineManagement of mCRC with Erbitux ™ in combination with Chemotherapy"	Merck Serono	Rejected	ERBITUX	4	EMR062202_	N/A
"A prospective, observational, non-randomized, European, multi-centerregistry, collecting REal-life information for the utilization of instantaneouswave-free ratio™ (iFR®) in Assessing coronary stenosis relevance in theMulti-vesseL disease patients population."	Volcano	Rejected	VOLCAO-iFR®	4	2014-CV-00	N/A
A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men who are at High Risk for Poor Clinical Outcomes after Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men with Castration-Resistant Prostate Cancer and Men with Metastatic Prostate Cancer at Initial Diagnosis	Astellas	Rejected	-	4	ONC-MA1001	N/A
RETROSPECTIVE EPIDEMIOLOGY STUDY OF ALK REARRANGEMENT IN NON-SMALL CELL LUNG CANCER PATIENTS IN THE MIDDLE EAST & NORTH AFRICA	Pfizer	Rejected	-	4	A8081046	N/A
"(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated "	Novartis	Completed	Ranibizumab 10mg/ml (Lucentis)	4	RFB002A2406	King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), Prince Sultan Military Medical City (Riyadh)
An observational study to evaluate the effectiveness, safty and effect on health-related quality of life of treatment in routine practice (PERFORMS)	Novartis	Completed	Fingolimod	4	CFTY720D-MAX-TH-01	King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Jeddah)